5 Results for "

p38 MAPK-IN-2

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "p38 MAPK-IN-2" in MCE Product Catalog:

Cat. No.: HY-U00324
CAS No.: 635725-16-5
Target:  

p38 MAPK Autophagy

Research Areas:  

Cancer

p38 MAPK-IN-2 is an inhibitor of p38 kinase.
loading...
    loading...
Cat. No.: HY-178433
Research Areas:  

Neurological Disease

BChE/p38-α MAPK-IN-2 is a BChE and p38-α MAPK dual inhibitor. BChE/p38-α MAPK-IN-2 inhibits hBChE with an IC50 of 5.1 nM, showing 1000-fold selectivity over hAChE. BChE/p38-α MAPK-IN-2 inhibits p38α MAPK with an IC50 of 8.12 μM. BChE/p38-α MAPK-IN-2 exhibits neuroprotective effect and can be used for the research of neurological disease, such as Alzheimer’s disease .
loading...
    loading...
Cat. No.: HY-168482
CAS No.: 3070509-60-0
Target:  

NF-κB p38 MAPK

Research Areas:  

Cancer

NF-κB/MAPK-IN-2 (compound 14) is a potent NF-κB and MAPK Inhibitor. NF-κB/MAPK-IN-2 decreases the protein expression of p-p65, p-IκB, p-p38, p-JNK, and p-ERK. NF-κB/MAPK-IN-2 reduces the LPS-induced release of TNF-α and IL-6. NF-κB/MAPK-IN-2 inhibits nuclear translocation of p65 and c-Fos. NF-κB/MAPK-IN-2 has the potential for the research of sepsis .
loading...
    loading...
Cat. No.: HY-152087
CAS No.: 2789629-84-9
Target:  

ERK p38 MAPK

Research Areas:  

Cardiovascular Disease

DCZ19931 is a potent multi-targeting kinase inhibitor. DCZ19931 has anti-angiogenic effects on ocular neovascularization. DCZ19931 also inhibits ERK1/2-MAPK and p38-MAPK signaling .
loading...
    loading...
Cat. No.: HY-162228
CAS No.: 3050874-42-2
Target:  

COX Phospholipase

Research Areas:  

Inflammation/Immunology

VI-60 is a dual, orally active inhibitor of cPLA2 and COX-2, which reveals an anti-inflammtory efficacy through the inhibition of p38 MAPK/cPLA2/COX-2/PGE2 pathway .
loading...
    loading...